Recall
FDAHealthSeptember 19, 2023

NeuroSync, Inc. — NeuroSync EYE-SYNC containing Pico Neo 2 Headsets. Each unit consists of a Pico Neo 2 headset with embedded sensors, a paired Android tablet, and proprietary software, packaged in a

⚠️ Eye syncing issues causing the device to be inoperable. Unable to be repaired due to discontinuation of support for the Pico 2 platform, which was no longer in production or serviceable as of August 31, 2023.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
September 19, 2023

United States Nationwide distribution in the states of New York (NY), Texas (TX), and Georgia (GA).

What's affected?

Product
NeuroSync EYE-SYNC containing Pico Neo 2 Headsets. Each unit consists of a Pico Neo 2 headset with embedded sensors, a paired Android tablet, and proprietary software, packaged in a portable field case. Eye-tracking headset system is intended for recording, viewing, and analyzing eye movements in support of identifying visual tracking impairment in human subjects. The EYE-SYNC is intended to record, measure, and analyze eye movements as an aid in the diagnosis of concussion, also known as mild traumatic brain injury (mTBI).
Lot code
P-10114-13)

Additional details

Model No X02. UDI-DI: 00868096000300. Serial Numbers: PA7D50NGF4020311G (Lot P-10114-13), PA7D50NGF4020191G (Lot P-10114-13), PA7D40NGEA080237G (Lot P-10114-12) Software Revisions: Software version uniform across all affected devices

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 27 units.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.